首页> 外国专利> Compounds derived from Mandelic acid, Thrombin Inhibitors, Preparation procedures, Intermediate Compounds, Pharmaceutical composition,Useful in the treatment of Thrombosis or as anticoagulant.

Compounds derived from Mandelic acid, Thrombin Inhibitors, Preparation procedures, Intermediate Compounds, Pharmaceutical composition,Useful in the treatment of Thrombosis or as anticoagulant.

机译:衍生自扁桃酸的化合物,凝血酶抑制剂,制备步骤,中间化合物,药物组合物,可用于治疗血栓形成或用作抗凝剂。

摘要

There is provided a compound of formula I wherein R a , R 1 , R 2 , Y and R 3 have meanings given in the description and pharmaceutically-acceptable derivatives (including prodrugs) thereof, which compounds and derivatives are useful as, or are useful as prodrugs of, competitive inhibitors of trypsin-like proteases, such as thrombin, and thus, in particular, in the treatment of conditions where inhibition of thrombin is required (e.g. thrombosis) or as anticoagulants.
机译:提供了式I化合物其中R a,R 1,R 2,Y和R 3具有说明书中给出的含义及其药学上可接受的衍生物(包括前药),该化合物和衍生物可用作或作为胰蛋白酶竞争性抑制剂的前药-类蛋白酶,例如凝血酶,因此,特别是在需要抑制凝血酶(例如血栓形成)或作为抗凝剂的疾病的治疗中。

著录项

  • 公开/公告号IS2755B

    专利类型

  • 公开/公告日2011-09-15

    原文格式PDF

  • 申请/专利权人 ASTRAZENECA AB;

    申请/专利号IS20030006828

  • 申请日2003-05-27

  • 分类号C07D205/04;A61K31/397;A61K31/401;A61K31/42;A61K31/4427;A61K31/506;A61P7/02;A61P9;A61P9/10;C07C37/055;C07C39/27;C07C45;C07C45/29;C07C45/45;C07C45/51;C07C45/67;C07C45/71;C07C47/565;C07C47/575;C07C49/84;C07C59/52;C07C59/56;C07C59/64;C07C69/732;C07C69/734;C07C69/738;C07C205/59;C07D207/10;C07D207/16;C07D263/58;C07D401/12;C07D403/12;C07D413/12;

  • 国家 IS

  • 入库时间 2022-08-21 18:05:34

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号